Reports
Reports
Sale
The global cloning and mutagenesis market size is estimated to grow in the forecast period of 2023-2028 at a CAGR of 17.0%
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is holding a significant share in the cloning and mutagenesis market and is expected to register robust growth during the forecast period. This is on account of the huge investments in the research and development in the medical field, coupled with the well-developed healthcare industry in the region.
Rising investments in biotechnology companies and presence of market key players like Thermo Fisher Scientific Inc. and Codex DNA, Inc., among others is expected to drive the market growth. Moreover, the surging investment in the development of stem cell and cancer cell studies is further anticipated to bolster the market growth in North America.
Meanwhile, the Asia Pacific region is expected to witness considerable market growth due to the rapidly growing healthcare industry and increasing investments in biotechnology.
Cloning refers to the creation of duplicates of organisms either artificially, or naturally, with nearly identical DNA coding. Mutagenesis is a method of changing the genetic information of an organism encoded into the DNA. The adaptation and changes are performed in laboratory settings. Both techniques are used and under continued development to understand the relation of proteins.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the cloning and mutagenesis market is divided into:
Based on technique, the market is categorised into:
On the basis of end use, the market is segmented into:
The EMR report looks into the regional markets of cloning and mutagenesis like Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The cloning and mutagenesis market is projected to witness substantial growth during the forecast period on account of the surging popularity of reproductive cloning. Going further, the various innovation and launch of product in the industry are proliferating the growth of the market. The rising penetration of personalised medications along with surging diseases is further expected to boost the market growth across the globe.
The growing cases of diseases such as cancer and HIV coupled with surging investment in the research of treatment for genetic diseases are propelling the market demand. The increasing efforts by governments such as providing funds for medical research coupled with the development of the biotechnology industry are encouraging the potential growth of the industry.
The report presents a detailed analysis of the following key players in the global cloning and mutagenesis market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Technique |
|
Breakup by End Use |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Cloning and Mutagenesis Market Analysis
8.1 Key Industry Highlights
8.2 Global Cloning and Mutagenesis Historical Market (2018-2022)
8.3 Global Cloning and Mutagenesis Market Forecast (2023-2028)
8.4 Global Cloning and Mutagenesis Market by Product
8.4.1 Cloning Kits
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Mutagenesis Kit
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.5 Global Cloning and Mutagenesis Market by Technique
8.5.1 Topo PCR Cloning
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 Blunt End Cloning
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.5.3 Seamless Cloning
8.5.3.1 Historical Trend (2018-2022)
8.5.3.2 Forecast Trend (2023-2028)
8.5.4 Site-Directed Mutagenesis
8.5.4.1 Historical Trend (2018-2022)
8.5.4.2 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Cloning and Mutagenesis Market by End Use
8.6.1 Biotechnology Companies
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Academic and Research Institute
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Cloning and Mutagenesis Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2018-2022)
8.7.1.2 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Historical Trend (2018-2022)
8.7.2.2 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2018-2022)
8.7.3.2 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Historical Trend (2018-2022)
8.7.4.2 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2018-2022)
8.7.5.2 Forecast Trend (2023-2028)
9 North America Cloning and Mutagenesis Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Cloning and Mutagenesis Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Cloning and Mutagenesis Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Cloning and Mutagenesis Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Cloning and Mutagenesis Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Thermo Fisher Scientific Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Takara Bio Inc.
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Codex DNA, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Agilent Technologies, Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 TransGen Biotech Co., Ltd.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Cloning and Mutagenesis Market: Key Industry Highlights, 2018 and 2028
2. Global Cloning and Mutagenesis Historical Market: Breakup by Product (USD Million), 2018-2022
3. Global Cloning and Mutagenesis Market Forecast: Breakup by Product (USD Million), 2023-2028
4. Global Cloning and Mutagenesis Historical Market: Breakup by Technique (USD Million), 2018-2022
5. Global Cloning and Mutagenesis Market Forecast: Breakup by Technique (USD Million), 2023-2028
6. Global Cloning and Mutagenesis Historical Market: Breakup by End Use (USD Million), 2018-2022
7. Global Cloning and Mutagenesis Market Forecast: Breakup by End Use (USD Million), 2023-2028
8. Global Cloning and Mutagenesis Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Cloning and Mutagenesis Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Cloning and Mutagenesis Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Cloning and Mutagenesis Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Cloning and Mutagenesis Market Structure
The global market is assessed to grow at a CAGR of 17.0% between 2023 and 2028.
The major market drivers are the high per capita healthcare expenditure and increasing investment by government in medical research.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The key market trends include emerging economies along with surging cases of chronic diseases and the increasing investment in biotechnology.
The common types of products types in the market include cloning kits and mutagenesis kit.
The primary techniques used include topo PCR cloning, blunt end cloning, seamless cloning, and site-directed mutagenesis, among others.
The various end uses in the market include biotechnology companies, and academic and research institute, among others.
The major players in the market are Thermo Fisher Scientific Inc., Takara Bio Inc., Codex DNA, Inc., Agilent Technologies, Inc., and TransGen Biotech Co., Ltd., among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.